# Evaluation of the Efficacy and Safety of Diclofenac HPBCD 25, 50 mg/ml in the Treatment of Post-surgical Pain Following Dental Surgery

> **NCT00942448** · PHASE3 · COMPLETED · sponsor: **IBSA Institut Biochimique SA** · enrollment: 306 (actual)

## Conditions studied

- Dental Pain

## Interventions

- **DRUG:** Diclofenac HPBCD
- **DRUG:** Diclofenac HPBCD
- **DRUG:** Diclofenac HPBCD
- **OTHER:** Placebo s.c.

## Key facts

- **NCT ID:** NCT00942448
- **Lead sponsor:** IBSA Institut Biochimique SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-01
- **Final completion:** 2010-04
- **Target enrollment:** 306 (ACTUAL)
- **Last updated:** 2013-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00942448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00942448, "Evaluation of the Efficacy and Safety of Diclofenac HPBCD 25, 50 mg/ml in the Treatment of Post-surgical Pain Following Dental Surgery". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00942448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*